Abstract
Objective How responsive neurostimulation (RNS) decreases seizure frequency is unclear. Stimulation may alter epileptic networks during inter-ictal epochs. Since fast ripples (FR) may be a substrate of the epileptic network, we examined whether stimulation of FR generating networks differed in RNS super- and intermediate-responders.
Methods In 10 patients, we detected FR during sleep from stereo EEG (SEEG) contacts during the pre-surgical evaluation in patients with subsequent RNS placement. The normalized coordinates of the SEEG contacts were compared with that of the eight RNS contacts, and RNS stimulated SEEG contacts were defined as within 1.5 cm3 of the RNS contacts. We compared the post-RNS placement seizure outcome to 1) the ratio of stimulated SEEG contacts in the seizure-onset zone (SOZ SR); 2) the ratio of FR events on stimulated contacts (FR SR); and 3) the global efficiency of the FR temporal correlational network on stimulated contacts (FR SGe).
Results We found that the SOZ SR (p=0.18) and FR SR (p=0.06) did not differ in the RNS super- and intermediate-responders, but the FR SGe did (p=0.02). In super-responders highly active desynchronous sites of the FR network were stimulated.
Significance RNS that better targets FR networks, as compared to the SOZ, may reduce epileptogenicity more.
Short summary Responsive neurostimulation (RNS) may reduce seizures by altering the epileptic network. Fast ripples (FR) may be a substrate of the epileptic network. We investigated, in 10 patients, if RNS stimulation of FR generating brain differed in RNS super-responders and intermediate-responders. The RNS stimulated brain sites were defined as contacts in the pre-surgical stereo EEG implant within 1.5 cm3 of the subsequently placed RNS stimulation contacts. FR events were more highly active and temporally desynchronous (p<0.05) on the stimulated contacts in the RNS super-responders. We show RNS that better targets FR networks, as compared to the seizure onset zone, may reduce epileptogenicity more.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was fully supported by the National Institute of Health K23 NS094633, a Junior Investigator Award from the American Epilepsy Society (S.A.W.), R01 NS106958 (R.J.S.) and R01 NS033310 (J.E.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Thomas Jefferson University Institutional Review Board gave ethical approval of this work. University of California Institutional Review Board gave ethical approval of this work. State University of New York Downstate waived ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
